The Scientific and Research Team at TB Alliance spearheads the discovery, development, and optimization of new tuberculosis drug regimens. Comprising experts in biology, preclinical and clinical project management, medical affairs, chemistry, and R&D, the team collaborates on innovative approaches to create faster-acting, affordable treatments, ultimately aiming to eliminate deaths from tuberculosis worldwide.
View all